| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥12187.1B | ¥13388.4B | -9.0% |
| Operating Income | ¥546.4B | ¥669.0B | -18.3% |
| Profit Before Tax | ¥515.3B | ¥659.5B | - |
| Net Income | ¥333.6B | ¥462.6B | -27.9% |
| ROE | 3.3% | 4.8% | - |
Mitsui Chemicals' FY2026 Q3 consolidated results show revenue of 1,218.7 billion yen (YoY -9.0%), operating income of 54.6 billion yen (YoY -18.3%), and net income attributable to owners of 33.4 billion yen (YoY -27.9%). The company experienced double-digit declines in both operating and net income, with operating margin compressing to approximately 4.5%, indicating deteriorating business profitability. Comprehensive income reached 72.8 billion yen, significantly exceeding net income due to other comprehensive income contributions of 39.5 billion yen from fair value adjustments and pension remeasurements. Despite profitability headwinds, operating cash flow remained robust at 140.9 billion yen, demonstrating strong cash generation capability with an operating CF to net income ratio of 6.24 times.
[Profitability] Return on equity stood at 2.2%, decomposed into net profit margin of 1.9%, asset turnover of 0.55 times, and financial leverage of 2.20 times, indicating significant room for improvement across all DuPont components. Operating margin of 4.5% and return on assets of 1.5% both reflect compressed profitability from the prior year. Return on invested capital of 3.5% suggests suboptimal capital allocation efficiency. The EBIT margin deterioration stems from revenue decline of 9.0% coupled with selling, general and administrative expenses remaining elevated at 215.2 billion yen. Equity method investment income contributed 13.9 billion yen to earnings, providing partial offset to operating weakness. [Cash Quality] Cash and cash equivalents totaled 192.2 billion yen against current assets of 1,015.2 billion yen. Operating cash flow of 140.9 billion yen substantially exceeded net income, indicating healthy cash-backed earnings quality. The accrual ratio of negative 5.4% suggests minimal earnings quality concerns from accrual manipulation. [Investment Efficiency] Asset turnover of 0.55 times and working capital metrics show days sales outstanding of 91 days, days inventory outstanding of 171 days, and cash conversion cycle of 204 days, all indicating slower capital velocity compared to manufacturing sector norms. Capital expenditure of 92.5 billion yen relative to depreciation suggests ongoing investment in productive capacity. [Financial Health] Equity ratio of 39.7% with total equity of 1,005.2 billion yen against total assets of 2,209.1 billion yen maintains adequate solvency. Debt-to-equity ratio of 1.20 times remains within manageable parameters. Current ratio provides sufficient short-term liquidity coverage, though working capital efficiency warrants monitoring given extended operating cycle days.
Operating cash flow of 140.9 billion yen represents 6.24 times net income, confirming strong cash generation despite earnings compression, primarily driven by substantial non-cash adjustments including depreciation and deferred tax items. Within operating activities, trade payables decreased by 12.6 billion yen while other working capital increased by 22.4 billion yen, creating headwinds to cash generation and suggesting inventory accumulation pressures with inventories rising 8.3 billion yen. The company paid corporate income taxes of 15.8 billion yen, interest expenses of 6.0 billion yen, and lease payments of 7.1 billion yen during the period. Investing cash flow of negative 96.9 billion yen was dominated by capital expenditures of 92.5 billion yen and intangible asset acquisitions of 7.6 billion yen, reflecting continued strategic investment in productive assets. Free cash flow of 44.0 billion yen, while positive, provides limited cushion after covering substantial capital investment requirements. Financing cash flow of negative 30.9 billion yen primarily reflected debt repayments and dividend distributions of 28.2 billion yen. The cash position of 192.2 billion yen provides adequate coverage of short-term obligations, though the combination of elevated capital expenditure, working capital consumption, and substantial dividend payments creates moderate cash allocation pressure that requires careful monitoring of liquidity sustainability.
Operating income of 54.6 billion yen compared to ordinary income of 51.5 billion yen shows minimal non-operating contribution, with the slight negative differential of 3.1 billion yen offset by equity method investment gains of 13.9 billion yen that constitute a key recurring earnings component. Non-operating income composition includes financial income and foreign exchange fluctuations that are typical for a global chemicals manufacturer with international operations and raw material procurement exposure. The effective tax burden coefficient of 0.438 indicates elevated tax costs that compress after-tax profitability, with income tax expenses of 28.9 billion yen on profit before tax of 51.5 billion yen representing an effective rate substantially above standard corporate rates and warranting examination of tax structure optimization opportunities. Operating cash flow substantially exceeding net income by a factor of 6.24 times provides strong evidence of healthy earnings quality, as cash generation validates reported profits and suggests minimal dependence on aggressive accrual accounting. The divergence stems primarily from non-cash charges including depreciation and amortization, deferred tax adjustments, and equity method accounting treatments rather than revenue recognition or expense deferral concerns. Comprehensive income of 72.8 billion yen exceeded net income by 39.5 billion yen due to other comprehensive income components including fair value adjustments on securities and pension liability remeasurements, which represent balance sheet revaluations rather than core operating performance.
Product mix deterioration risk poses significant concern as operating margin compression to 4.5% suggests increasing proportion of lower-margin products or commoditized offerings, with EBIT margin falling below industry warning thresholds and requiring urgent attention to value-added product portfolio optimization. Working capital efficiency degradation creates cash flow sustainability risk, with cash conversion cycle extending to 204 days driven by receivables collection of 91 days and inventory holding of 171 days, both substantially elevated relative to manufacturing sector benchmarks and consuming operating cash that could otherwise support growth investment or shareholder returns. Dividend sustainability risk emerges acutely from calculated payout ratio of 266.8 percent based on annual dividend of 150 yen per share against quarterly earnings trajectory, creating unsustainable capital allocation that would require either dividend reduction, significant earnings recovery, or incremental debt financing to maintain distribution levels through fiscal year end.
[Industry Position] (Reference - Proprietary Analysis) Profitability metrics show meaningful underperformance relative to manufacturing sector medians, with ROE of 2.2 percent trailing the industry median of 5.0 percent by 2.8 percentage points, net profit margin of 1.9 percent versus industry median of 6.3 percent indicating a 4.4 percentage point disadvantage, and operating margin of 4.5 percent falling 3.8 percentage points below the industry median of 8.3 percent. Financial health positioning shows equity ratio of 39.7 percent below the industry median of 63.8 percent, suggesting higher financial leverage relative to sector peers, though remaining within acceptable solvency ranges. Efficiency metrics reveal asset turnover of 0.55 times approximating the industry median of 0.58 times, indicating comparable asset utilization, while working capital metrics show receivables turnover of 91 days versus industry median of 83 days and inventory turnover of 171 days substantially exceeding industry median of 109 days by 62 days, highlighting significant working capital management challenges. The cash conversion cycle of 204 days compares unfavorably to industry norms, with operating working capital turnover notably extended. Return on invested capital of 3.5 percent falls below the industry median of 5.0 percent, confirming capital allocation efficiency concerns. Revenue growth of negative 9.0 percent significantly underperforms the industry median growth of positive 2.7 percent, placing the company in the bottom quartile of sector performance. (Industry: Manufacturing sector, N=98 companies for most metrics, Comparison: FY2025-Q3 industry medians, Source: Proprietary analysis)
Profitability recovery imperative emerges as the dominant financial narrative, with operating margin of 4.5 percent and ROE of 2.2 percent both requiring substantial improvement through product mix optimization toward higher value-added offerings, cost structure rationalization to align selling and administrative expenses with revenue trajectory, and operational efficiency gains to restore EBIT margins toward historical and industry-competitive levels. Working capital normalization represents critical near-term opportunity, as cash conversion cycle of 204 days with inventory holding period of 171 days and receivables collection of 91 days both exceed manufacturing sector benchmarks by significant margins, suggesting that targeted working capital initiatives including inventory reduction programs and accounts receivable acceleration could release substantial trapped cash to improve free cash flow generation and capital efficiency metrics. Capital allocation policy requires recalibration given dividend payout ratio of 266.8 percent creating unsustainable distribution levels relative to current earnings, necessitating either significant earnings recovery to justify maintained dividends, dividend policy adjustment to establish sustainable payout levels, or strategic portfolio actions to generate incremental cash flows, with current free cash flow of 44.0 billion yen insufficient to simultaneously fund elevated capital expenditure of 92.5 billion yen and dividend payments of 28.2 billion yen on a sustainable basis without balance sheet deterioration.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.